Publication | Open Access
Distinct recognition of complement iC3b by integrins α <sub>X</sub> β <sub>2</sub> and α <sub>M</sub> β <sub>2</sub>
55
Citations
34
References
2017
Year
Recognition by the leukocyte integrins α<sub>X</sub>β<sub>2</sub> and α<sub>M</sub>β<sub>2</sub> of complement iC3b-opsonized targets is essential for effector functions including phagocytosis. The integrin-binding sites on iC3b remain incompletely characterized. Here, we describe negative-stain electron microscopy and biochemical studies of α<sub>X</sub>β<sub>2</sub> and α<sub>M</sub>β<sub>2</sub> in complex with iC3b. Despite high homology, the two integrins bind iC3b at multiple distinct sites. α<sub>X</sub>β<sub>2</sub> uses the α<sub>X</sub> αI domain to bind iC3b on its C3c moiety at one of two sites: a major site at the interface between macroglobulin (MG) 3 and MG4 domains, and a less frequently used site near the C345C domain. In contrast, α<sub>M</sub>β<sub>2</sub> uses its αI domain to bind iC3b at the thioester domain and simultaneously interacts through a region near the α<sub>M</sub> β-propeller and β<sub>2</sub> βI domain with a region of the C3c moiety near the C345C domain. Remarkably, there is no overlap between the primary binding site of α<sub>X</sub>β<sub>2</sub> and the binding site of α<sub>M</sub>β<sub>2</sub> on iC3b. Distinctive binding sites on iC3b by integrins α<sub>X</sub>β<sub>2</sub> and α<sub>M</sub>β<sub>2</sub> may be biologically beneficial for leukocytes to more efficiently capture opsonized pathogens and to avoid subversion by pathogen factors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1